IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.

The role of Interleukin(IL)-6 in the pathogenesis of joint and systemic inflammation in rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis (s-JIA) has been clearly demonstrated. However, the mechanisms by which IL-6 contributes to the pathogenesis are not completely understood. Thi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ivan Caiello, Gaetana Minnone, Dirk Holzinger, Thomas Vogl, Giusi Prencipe, Antonio Manzo, Fabrizio De Benedetti, Raffaele Strippoli
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/070f91beb0554633afb82599341e1c96
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:070f91beb0554633afb82599341e1c96
record_format dspace
spelling oai:doaj.org-article:070f91beb0554633afb82599341e1c962021-11-25T05:58:21ZIL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.1932-620310.1371/journal.pone.0107886https://doaj.org/article/070f91beb0554633afb82599341e1c962014-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0107886https://doaj.org/toc/1932-6203The role of Interleukin(IL)-6 in the pathogenesis of joint and systemic inflammation in rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis (s-JIA) has been clearly demonstrated. However, the mechanisms by which IL-6 contributes to the pathogenesis are not completely understood. This study investigates whether IL-6 affects, alone or upon toll like receptor (TLR) ligand stimulation, the production of inflammatory cytokines and chemokines in human peripheral blood mononuclear cells (PBMCs), synovial fluid mononuclear cells from JIA patients (SFMCs) and fibroblast-like synoviocytes from rheumatoid arthritis patients (RA synoviocytes) and signalling pathways involved. PBMCs were pre-treated with IL-6 and soluble IL-6 Receptor (sIL-6R). SFMCs and RA synoviocytes were pre-treated with IL-6/sIL-6R or sIL-6R, alone or in combination with Tocilizumab (TCZ). Cells were stimulated with LPS, S100A8-9, poly(I-C), CpG, Pam2CSK4, MDP, IL-1β. Treatment of PBMCs with IL-6 induced production of TNF-α, CXCL8, and CCL2, but not IL-1β. Addition of IL-6 to the same cells after stimulation with poly(I-C), CpG, Pam2CSK4, and MDP induced a significant increase in IL-1β and CXCL8, but not TNF-α production compared with TLR ligands alone. This enhanced production of IL-1β and CXCL8 paralleled increased p65 NF-κB activation. In contrast, addition of IL-6 to PBMCs stimulated with LPS or S100A8-9 (TLR-4 ligands) led to reduction of IL-1β, TNF-α and CXCL8 with reduced p65 NF-κB activation. IL-6/IL-1β co-stimulation increased CXCL8, CCL2 and IL-6 production. Addition of IL-6 to SFMCs stimulated with LPS or S100A8 increased CXCL8, CCL2 and IL-1β production. Treatment of RA synoviocytes with sIL-6R increased IL-6, CXCL8 and CCL2 production, with increased STAT3 and p65 NF-κB phosphorylation. Our results suggest that IL-6 amplifies TLR-induced inflammatory response. This effect may be relevant in the presence of high IL-6 and sIL-6R levels, such as in arthritic joints in the context of stimulation by endogenous TLR ligands.Ivan CaielloGaetana MinnoneDirk HolzingerThomas VoglGiusi PrencipeAntonio ManzoFabrizio De BenedettiRaffaele StrippoliPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 10, p e107886 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ivan Caiello
Gaetana Minnone
Dirk Holzinger
Thomas Vogl
Giusi Prencipe
Antonio Manzo
Fabrizio De Benedetti
Raffaele Strippoli
IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
description The role of Interleukin(IL)-6 in the pathogenesis of joint and systemic inflammation in rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis (s-JIA) has been clearly demonstrated. However, the mechanisms by which IL-6 contributes to the pathogenesis are not completely understood. This study investigates whether IL-6 affects, alone or upon toll like receptor (TLR) ligand stimulation, the production of inflammatory cytokines and chemokines in human peripheral blood mononuclear cells (PBMCs), synovial fluid mononuclear cells from JIA patients (SFMCs) and fibroblast-like synoviocytes from rheumatoid arthritis patients (RA synoviocytes) and signalling pathways involved. PBMCs were pre-treated with IL-6 and soluble IL-6 Receptor (sIL-6R). SFMCs and RA synoviocytes were pre-treated with IL-6/sIL-6R or sIL-6R, alone or in combination with Tocilizumab (TCZ). Cells were stimulated with LPS, S100A8-9, poly(I-C), CpG, Pam2CSK4, MDP, IL-1β. Treatment of PBMCs with IL-6 induced production of TNF-α, CXCL8, and CCL2, but not IL-1β. Addition of IL-6 to the same cells after stimulation with poly(I-C), CpG, Pam2CSK4, and MDP induced a significant increase in IL-1β and CXCL8, but not TNF-α production compared with TLR ligands alone. This enhanced production of IL-1β and CXCL8 paralleled increased p65 NF-κB activation. In contrast, addition of IL-6 to PBMCs stimulated with LPS or S100A8-9 (TLR-4 ligands) led to reduction of IL-1β, TNF-α and CXCL8 with reduced p65 NF-κB activation. IL-6/IL-1β co-stimulation increased CXCL8, CCL2 and IL-6 production. Addition of IL-6 to SFMCs stimulated with LPS or S100A8 increased CXCL8, CCL2 and IL-1β production. Treatment of RA synoviocytes with sIL-6R increased IL-6, CXCL8 and CCL2 production, with increased STAT3 and p65 NF-κB phosphorylation. Our results suggest that IL-6 amplifies TLR-induced inflammatory response. This effect may be relevant in the presence of high IL-6 and sIL-6R levels, such as in arthritic joints in the context of stimulation by endogenous TLR ligands.
format article
author Ivan Caiello
Gaetana Minnone
Dirk Holzinger
Thomas Vogl
Giusi Prencipe
Antonio Manzo
Fabrizio De Benedetti
Raffaele Strippoli
author_facet Ivan Caiello
Gaetana Minnone
Dirk Holzinger
Thomas Vogl
Giusi Prencipe
Antonio Manzo
Fabrizio De Benedetti
Raffaele Strippoli
author_sort Ivan Caiello
title IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
title_short IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
title_full IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
title_fullStr IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
title_full_unstemmed IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
title_sort il-6 amplifies tlr mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/070f91beb0554633afb82599341e1c96
work_keys_str_mv AT ivancaiello il6amplifiestlrmediatedcytokineandchemokineproductionimplicationsforthepathogenesisofrheumaticinflammatorydiseases
AT gaetanaminnone il6amplifiestlrmediatedcytokineandchemokineproductionimplicationsforthepathogenesisofrheumaticinflammatorydiseases
AT dirkholzinger il6amplifiestlrmediatedcytokineandchemokineproductionimplicationsforthepathogenesisofrheumaticinflammatorydiseases
AT thomasvogl il6amplifiestlrmediatedcytokineandchemokineproductionimplicationsforthepathogenesisofrheumaticinflammatorydiseases
AT giusiprencipe il6amplifiestlrmediatedcytokineandchemokineproductionimplicationsforthepathogenesisofrheumaticinflammatorydiseases
AT antoniomanzo il6amplifiestlrmediatedcytokineandchemokineproductionimplicationsforthepathogenesisofrheumaticinflammatorydiseases
AT fabriziodebenedetti il6amplifiestlrmediatedcytokineandchemokineproductionimplicationsforthepathogenesisofrheumaticinflammatorydiseases
AT raffaelestrippoli il6amplifiestlrmediatedcytokineandchemokineproductionimplicationsforthepathogenesisofrheumaticinflammatorydiseases
_version_ 1718414321613012992